G. Cropp
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 25
- Cancer Treatment and Pharmacology 21
- Colorectal Cancer Treatments and Studies 6
-
- Ubiquitin and proteasome pathways 6
- Angiogenesis and VEGF in Cancer 5
- Cancer therapeutics and mechanisms 5
- Co-authors
- Alison L. Hannah (26 shared papers)Alison Stopeck (4 shared papers)Robert G. Johnson (15 shared papers)Shanu Modi (2 shared papers)Michael S. Gordon (3 shared papers)Weining Ma (2 shared papers)Jennifer J. Wheler (2 shared papers)Neal Rosen (1 shared paper)
- Journals
- Journal of Clinical Oncology (19 papers)Blood (9 papers)Cancer Chemotherapy and Pharmacology (2 papers)Investigational New Drugs (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesAustraliaEstonia
In The Last Decade
G. Cropp
41 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 74
- Oncology 473
- Hematology 177
- Cell Biology 155
- Molecular Biology 612
- Cancer Research 123
Countries citing papers authored by G. Cropp
This map shows the geographic impact of G. Cropp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Cropp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Cropp more than expected).
Fields of papers citing papers by G. Cropp
This network shows the impact of papers produced by G. Cropp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Cropp. The network helps show where G. Cropp may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Cropp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 278 | |
| 2 | Results of a Phase I dose-escalating study of the antiangiogenic agent, SU5416, in patients with advanced malignancies. | 2002 | 127 |
| 3 | 2002 | 118 | |
| 4 | 2010 | 95 | |
| 5 | 1999 | 60 | |
| 6 | 2001 | 41 | |
| 7 | 2006 | 30 | |
| 8 | 2005 | 29 | |
| 9 | 2005 | 28 | |
| 10 | 2004 | 27 | |
| 11 | 2006 | 26 | |
| 12 | 2009 | 25 | |
| 13 | 2007 | 23 | |
| 14 | 2004 | 23 | |
| 15 | 2007 | 20 | |
| 16 | 2006 | 18 | |
| 17 | 2003 | 18 | |
| 18 | 2011 | 17 | |
| 19 | 2005 | 15 | |
| 20 | 2009 | 12 |
About G. Cropp
G. Cropp is a scholar working on Oncology, Molecular Biology, Cancer Research, Hematology and Pulmonary and Respiratory Medicine, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (21 papers), Cancer, Hypoxia, and Metabolism (9 papers), Multiple Myeloma Research and Treatments (8 papers), Ubiquitin and proteasome pathways (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Angiogenesis and VEGF in Cancer (5 papers), Cancer therapeutics and mechanisms (5 papers) and Microtubule and mitosis dynamics (3 papers). The work is most often cited by research in Oncology (473 citations), Hematology (177 citations), Cell Biology (155 citations), Molecular Biology (612 citations) and Cancer Research (123 citations). G. Cropp has collaborated with scholars based in United States, Australia and Estonia. Frequent co-authors include Alison L. Hannah, Alison Stopeck, Robert G. Johnson, Shanu Modi, Michael S. Gordon, Weining Ma, Jennifer J. Wheler, Neal Rosen, Larry Norton and David S. Mendelson. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Chemotherapy and Pharmacology, Investigational New Drugs and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.